Overcomplicated GLP-1 Guidelines May Discourage Prescribing Yoni Freedhoff, MD

https://www.medscape.com/viewarticle/overcomplicated-glp-1-guidelines-may-discourage-prescribing-2026a1000qq0?ecd=mkm_ret_260821_mscpmrk-OUS_ICYMI_etid8612371&uac=148436CN&impID=8612371 The Lancet Diabetes & Endocrinology recently published a consensus piece on using GLP-1 medications for obesity in Europe. The paper, "Nutritional, Functional, and Psychological Considerations for Incretin-Based Therapies in Adults—an EASO, EFAD, and ECPO Consensus Statement", aimed to provide guidance on best practices for clinicians prescribing obesity medications — but one could argue, it's more likely to lead clinicians to feel ill equipped than empowered.